sterl drug inc said submit new drug applic food and drug administr for permiss market oral form corotrop milrinon drug for treat chronic congest heart failur sterl said applic includ seri studi 952 patient and result three multicent studi involv anoth 571 patient demonstr efficaci and safeti drug altern digitali reuter 